Pathway Genomics Corporation (“Pathway”) announced a settlement agreement that ends the BRCA patent litigation against Pathway that began on June ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE